CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway
Background. Hepatocellular carcinoma (HCC) is a highly aggressive and solid malignancy with a poor prognosis. Cell division cycle associated 2 (CDCA2) is highly expressed in HCC and is considered to be closely related to the prognosis of patients with HCC. In this research, we aimed to investigate t...
Saved in:
| Main Authors: | Kai Li, Tingting Fan, Zhongxing Shi, Huijie Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2022/9912254 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway
by: Lu X, et al.
Published: (2025-04-01) -
Exportin-T Promotes Breast Cancer Progression via PI3K/AKT/mTOR Signaling Pathway
by: Hou Z, et al.
Published: (2025-05-01) -
Taletrectinib promotes pyroptosis in colorectal carcinoma via SRC/AKT/mTOR axis inhibition
by: Ting Zhang, et al.
Published: (2025-05-01) -
TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation
by: Kaiwen Zhang, et al.
Published: (2024-12-01) -
CD147-high extracellular vesicles promote gastric cancer metastasis via VEGF/AKT/eNOS and AKT/mTOR pathways
by: Chen-li Zhang, et al.
Published: (2025-06-01)